Effect of trastuzumab in combination with IFN α-2b on HER2 and MRP1 of ACHN

Abstract

To study the effect of Trastuzumab in combination with IFN α-2b on HER2 and MRP1 of ACHNin vitro, ACHN cell line of RCC was cultured by employing cell culture. The tetrazolium-based colorimetric assay was used to evaluate the growth-inhibiting effect of Trastuzumab with IFN α-2b. SP method was utilized to determine the expression of HER2 and MRP1 of the cells. Our results showed that Trastuzumab had inhibitory effect on the growth of renal tumor cells and reversing effect on the multi-drug-resistance (MDR) in RCC in a time- and dose-dependent manner. Treated with Trastuzumab with or without IFN α-2b, the expression of HER2 and MRP1 genes of RCC was decreased significantly (P<0.05). It was concluded that Trastuzumab with IFN α-2b could inhibit the proliferation of RCC and the expression of HER2 and MRP1 of ACHN and to some extent, reverse the MDR of the tumor cells.

Keywords

renal cell carcinoma / trastuzumab / IFN α-2b / HER2 / MRP1

References

[1] FanY Z, FuJ Y, ZhaoZ M, et al.. Thein vitro effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells and its mechanism. Zhonghua Zhong Liu Za Zhi (Chinese), 2004, 26(5): 271-271

[2] MenardS, TagliabueE, CampiglioM, et al.. Role of HER2 gene overexpression in breast carcinoma. J Cell physiol, 2000, 182(2): 150-150

[3] TanM, YaoJ, YuD, et al.. Overexpression of the cerbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res, 1997, 57(5): 1199-1199

[4] LigibleJ A, WinerE P. Trastuzumab/Chemotherapy combinations in metastatic breast cancer. Semin Oncol, 2002, 29(11): 38-38

[5] SchefferG L, MaliepaardM, PijnenborgA C, et al.. Breast cancer resistance protein is localized at the plasma membrane in mitinantrone- and topotecan-resistant cell lines. Cancer Res, 2000, 60(10): 2589-2589

[6] BenderraZ, TrussardibA, MorjaniaH, et al.. Regulation of cellular gluthione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein. Eur J Cancer, 2000, 36(3): 428-428